0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-inflammatory Therapeutics Market Research Report 2026
Published Date: 2026-03-02
|
Report Code: QYRE-Auto-26L12736
Home | Market Reports
Global Anti inflammatory Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Anti-inflammatory Therapeutics Market Research Report 2026

Code: QYRE-Auto-26L12736
Report
2026-03-02
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-inflammatory Therapeutics Market Size

The global Anti-inflammatory Therapeutics market was valued at US$ 131150 million in 2025 and is anticipated to reach US$ 197370 million by 2032, at a CAGR of 6.1% from 2026 to 2032.

Anti-inflammatory Therapeutics Market

Anti-inflammatory Therapeutics Market

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report delivers a comprehensive overview of the global Anti-inflammatory Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-inflammatory Therapeutics. The Anti-inflammatory Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-inflammatory Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Anti-inflammatory Therapeutics Market Report

Report Metric Details
Report Name Anti-inflammatory Therapeutics Market
Accounted market size in 2025 US$ 131150 million
Forecasted market size in 2032 US$ 197370 million
CAGR 6.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Others
Segment by Application
  • Arthritis
  • Respiratory Diseases
  • Dermatology
  • Gastroenterology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Anti-inflammatory Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Anti-inflammatory Therapeutics Market growing?

Ans: The Anti-inflammatory Therapeutics Market witnessing a CAGR of 6.1% during the forecast period 2026-2032.

What is the Anti-inflammatory Therapeutics Market size in 2032?

Ans: The Anti-inflammatory Therapeutics Market size in 2032 will be US$ 197370 million.

What is the AbbVie share in Anti-inflammatory Therapeutics Market?

Ans: AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share.

What is the Johnson & Johnson share in Anti-inflammatory Therapeutics Market?

Ans: Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Who are the main players in the Anti-inflammatory Therapeutics Market report?

Ans: The main players in the Anti-inflammatory Therapeutics Market are AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA

What are the Application segmentation covered in the Anti-inflammatory Therapeutics Market report?

Ans: The Applications covered in the Anti-inflammatory Therapeutics Market report are Arthritis, Respiratory Diseases, Dermatology, Gastroenterology, Others

What are the Type segmentation covered in the Anti-inflammatory Therapeutics Market report?

Ans: The Types covered in the Anti-inflammatory Therapeutics Market report are Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapeutics Market Perspective (2021–2032)
2.2 Global Anti-inflammatory Therapeutics Growth Trends by Region
2.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2021–2026)
2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2027–2032)
2.3 Anti-inflammatory Therapeutics Market Dynamics
2.3.1 Anti-inflammatory Therapeutics Industry Trends
2.3.2 Anti-inflammatory Therapeutics Market Drivers
2.3.3 Anti-inflammatory Therapeutics Market Challenges
2.3.4 Anti-inflammatory Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2021–2026)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2021–2026)
3.2 Global Top Anti-inflammatory Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Anti-inflammatory Therapeutics Revenue
3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2025
3.5 Global Key Players of Anti-inflammatory Therapeutics Head Offices and Areas Served
3.6 Global Key Players of Anti-inflammatory Therapeutics, Products and Applications
3.7 Global Key Players of Anti-inflammatory Therapeutics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Anti-inflammatory Therapeutics Breakdown Data by Type
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2021–2026)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2027–2032)
5 Anti-inflammatory Therapeutics Breakdown Data by Application
5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2021–2026)
5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size (2021–2032)
6.2 North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Anti-inflammatory Therapeutics Market Size by Country (2021–2026)
6.4 North America Anti-inflammatory Therapeutics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Market Size (2021–2032)
7.2 Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2021–2026)
7.4 Europe Anti-inflammatory Therapeutics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2021–2032)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2021–2026)
8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anti-inflammatory Therapeutics Market Size (2021–2032)
9.2 Latin America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Anti-inflammatory Therapeutics Market Size by Country (2021–2026)
9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2021–2032)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2021–2026)
10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Details
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Details
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapeutics Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapeutics Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Details
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2021–2026)
11.12.5 TEVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Anti-inflammatory Biologics
 Table 3. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
 Table 4. Key Players of Corticosteroids
 Table 5. Key Players of Others
 Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Anti-inflammatory Therapeutics Market Share by Region (2021–2026)
 Table 10. Global Anti-inflammatory Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Anti-inflammatory Therapeutics Market Share by Region (2027–2032)
 Table 12. Anti-inflammatory Therapeutics Market Trends
 Table 13. Anti-inflammatory Therapeutics Market Drivers
 Table 14. Anti-inflammatory Therapeutics Market Challenges
 Table 15. Anti-inflammatory Therapeutics Market Restraints
 Table 16. Global Anti-inflammatory Therapeutics Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Anti-inflammatory Therapeutics Market Share by Players (2021–2026)
 Table 18. Global Top Anti-inflammatory Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anti-inflammatory Therapeutics Revenue, 2025
 Table 19. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Anti-inflammatory Therapeutics, Headquarters and Area Served
 Table 22. Global Key Players of Anti-inflammatory Therapeutics, Products and Applications
 Table 23. Global Key Players of Anti-inflammatory Therapeutics, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Anti-inflammatory Therapeutics Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2021–2026)
 Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2027–2032)
 Table 29. Global Anti-inflammatory Therapeutics Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2021–2026)
 Table 31. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2027–2032)
 Table 33. North America Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Anti-inflammatory Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (US$ Million), 2027–2032
 Table 48. AbbVie Company Details
 Table 49. AbbVie Business Overview
 Table 50. AbbVie Anti-inflammatory Therapeutics Product
 Table 51. AbbVie Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 52. AbbVie Recent Development
 Table 53. Johnson & Johnson Company Details
 Table 54. Johnson & Johnson Business Overview
 Table 55. Johnson & Johnson Anti-inflammatory Therapeutics Product
 Table 56. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 57. Johnson & Johnson Recent Development
 Table 58. Amgen Inc Company Details
 Table 59. Amgen Inc Business Overview
 Table 60. Amgen Inc Anti-inflammatory Therapeutics Product
 Table 61. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 62. Amgen Inc Recent Development
 Table 63. AstraZeneca PLC Company Details
 Table 64. AstraZeneca PLC Business Overview
 Table 65. AstraZeneca PLC Anti-inflammatory Therapeutics Product
 Table 66. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 67. AstraZeneca PLC Recent Development
 Table 68. Pfizer, Inc Company Details
 Table 69. Pfizer, Inc Business Overview
 Table 70. Pfizer, Inc Anti-inflammatory Therapeutics Product
 Table 71. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 72. Pfizer, Inc Recent Development
 Table 73. Novartis Company Details
 Table 74. Novartis Business Overview
 Table 75. Novartis Anti-inflammatory Therapeutics Product
 Table 76. Novartis Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 77. Novartis Recent Development
 Table 78. Roche Company Details
 Table 79. Roche Business Overview
 Table 80. Roche Anti-inflammatory Therapeutics Product
 Table 81. Roche Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 82. Roche Recent Development
 Table 83. Merck Company Details
 Table 84. Merck Business Overview
 Table 85. Merck Anti-inflammatory Therapeutics Product
 Table 86. Merck Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 87. Merck Recent Development
 Table 88. Sanofi Company Details
 Table 89. Sanofi Business Overview
 Table 90. Sanofi Anti-inflammatory Therapeutics Product
 Table 91. Sanofi Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 92. Sanofi Recent Development
 Table 93. GlaxoSmithKline Company Details
 Table 94. GlaxoSmithKline Business Overview
 Table 95. GlaxoSmithKline Anti-inflammatory Therapeutics Product
 Table 96. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 97. GlaxoSmithKline Recent Development
 Table 98. Sun Pharmaceutical Industries Ltd Company Details
 Table 99. Sun Pharmaceutical Industries Ltd Business Overview
 Table 100. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
 Table 101. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 102. Sun Pharmaceutical Industries Ltd Recent Development
 Table 103. TEVA Company Details
 Table 104. TEVA Business Overview
 Table 105. TEVA Anti-inflammatory Therapeutics Product
 Table 106. TEVA Revenue in Anti-inflammatory Therapeutics Business (US$ Million), 2021–2026
 Table 107. TEVA Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Anti-inflammatory Therapeutics Picture
 Figure 2. Global Anti-inflammatory Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Anti-inflammatory Therapeutics Market Share by Type: 2025 vs 2032
 Figure 4. Anti-inflammatory Biologics Features
 Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
 Figure 6. Corticosteroids Features
 Figure 7. Others Features
 Figure 8. Global Anti-inflammatory Therapeutics Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Anti-inflammatory Therapeutics Market Share by Application: 2025 vs 2032
 Figure 10. Arthritis Case Studies
 Figure 11. Respiratory Diseases Case Studies
 Figure 12. Dermatology Case Studies
 Figure 13. Gastroenterology Case Studies
 Figure 14. Others Case Studies
 Figure 15. Anti-inflammatory Therapeutics Report Years Considered
 Figure 16. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 17. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Anti-inflammatory Therapeutics Market Share by Region: 2025 vs 2032
 Figure 19. Global Anti-inflammatory Therapeutics Market Share by Players in 2025
 Figure 20. Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2025
 Figure 22. North America Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. North America Anti-inflammatory Therapeutics Market Share by Country (2021–2032)
 Figure 24. United States Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Canada Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Anti-inflammatory Therapeutics Market Share by Country (2021–2032)
 Figure 28. Germany Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. France Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. U.K. Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Italy Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Russia Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Ireland Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Region (2021–2032)
 Figure 36. China Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. South Korea Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. India Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Australia & New Zealand Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Anti-inflammatory Therapeutics Market Share by Country (2021–2032)
 Figure 44. Mexico Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Brazil Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2021–2032)
 Figure 48. Israel Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. UAE Anti-inflammatory Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 52. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 53. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 54. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 55. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 56. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 57. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 58. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 59. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 60. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 61. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 62. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2021–2026)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS